Franklin Genomic Advancements ETF
HELX
7 hedge funds and large institutions have $2.49M invested in Franklin Genomic Advancements ETF in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
172% more capital invested
Capital invested by funds: $914K → $2.49M (+$1.57M)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
17% more funds holding
Funds holding: 6 → 7 (+1)
12.44% more ownership
Funds ownership: 11.08% → 23.51% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$95.6K |
| 2 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$94.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$15.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$219K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GS
1
GTS Securities
New York
| $1.35M | +$1.36M | +44,781 | New |
|
|
2
Jane Street
New York
| $384K | +$95.6K | +3,158 | +33% |
|
|
3
LPL Financial
San Diego,
California
| $252K | -$219K | -7,232 | -46% |
|
|
4
Commonwealth Equity Services
Waltham,
Massachusetts
| $239K | -$24K | -792 | -9% |
|
|
BFEC
5
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $234K | +$94.4K | +3,116 | +67% |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $18.7K | +$15.3K | +505 | +439% |
|
|
HI
7
Harbour Investments
Madison,
Wisconsin
| $5.68K | – | – | – |
|
8
JP Morgan Chase
New York
| $1 | – | – | – |
|
HELX Hedge Fund Activity: Q2 2023 in Review
7 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Franklin Genomic Advancements ETF (HELX) for Q2 2023, worth a combined $2.49M — up 172% from $914K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new HELX positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $95.6K. The largest seller was LPL Financial, cutting an estimated $219K.
- 7 institutional investors held Franklin Genomic Advancements ETF (HELX) as of Q2 2023, up from 6 in Q1 2023.
- Funds reported $2.49M of Franklin Genomic Advancements ETF stock for Q2 2023, up 172% quarter-over-quarter.
- 1 fund opened new Franklin Genomic Advancements ETF positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Franklin Genomic Advancements ETF buyer in Q2 2023 was Jane Street, an estimated $95.6K added.
- The largest Franklin Genomic Advancements ETF seller in Q2 2023 was LPL Financial, an estimated $219K sold.
Based on aggregated 13F filings for Q2 2023.